Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area cell cycle rock'

Search results for: 'research area cell cycle rock'

Items 41-50 of 228

Page
per page
  1. Wnt-C59
    A8685 Wnt-C59
     2 Citation
    Target: PORCN
    Summary: PORCN inhibitor,highly potent and selective
      .95 mg/mL
      insoluble in H2O; ≥18
  2. Salinomycin
    A3785 Salinomycin
    Target: Antibiotic
    Summary: Polyether ionophore antibiotic;anti-cancer
  3. ICG 001
    A8217 ICG 001
     1 Citation
    Summary: Wnt/β-catenin pathway inhibitor
      ≥27.43 mg/mL
  4. 6,2',4'-Trimethoxyflavone
    A8610 6,2',4'-Trimethoxyflavone
    Target: Aryl hydrocarbon receptors (AHRs)
    Summary: Aryl hydrocarbon receptor antagonist
      insoluble in DMSO
  5. CHIR-99021 (CT99021)
    A3011 CHIR-99021 (CT99021)
     2 Citation
    Target: GSK-3
    Summary: GSK-3 inhibitor, Cell-permeable, ATP-competitive
      ≥23.27 mg/mL
  6. 3-Deazaneplanocin A (DZNep) hydrochloride
    A8182 3-Deazaneplanocin A (DZNep) hydrochloride
     1 Citation
    Target: EZH2
    Summary: SAHH and EZH2 inhibitor
      insoluble in EtOH; ≥14.94 mg/mL
  7. AT13387
    A4056 AT13387
    Target: HSP90
    Summary: Hsp90 inhibitor
      insoluble in H2O; ≥13.25 mg/mL
  8. CI994 (Tacedinaline)
    A4102 CI994 (Tacedinaline)
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in H2O; insoluble in EtOH; ≥50 mg/mL
  9. CHIR-99021 (CT99021) HCl
    A8396 CHIR-99021 (CT99021) HCl
    Target: GSK-3
    Summary: GSK-3α/β inhibitor
      ≥25.1 mg/mL
  10. 3-Deazaneplanocin,DZNep
    A1905 3-Deazaneplanocin,DZNep
     6 Citation
    Target: Hydrolase
    Summary: S-adenosylhomocysteine and EZH2 inhibitor
      insoluble in EtOH; ≥17.07 mg/mL

Items 41-50 of 228

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 219item
  2. Natural Products 5item
  3. Kits 1 item
  4. Lab Reagents 3item
Specificity
  1. Selective 156item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 18item
  2. Irreversible 9item
Target
  1. Caspases 5item
  2. Cyclin-Dependent Kinases 14item
  3. Proteasome 5item
  4. Cathepsins 1 item
  5. Histone Deacetylases (HDACs) 13item
  6. Inhibitor of apoptosis proteins (IAP) 1 item
  7. Akt 1 item
  8. Bcl-2 2item
  9. PI3K 3item
  10. Raf 2item
  11. Aurora Kinases 3item
  12. Glycoproteins 1 item
  13. MDM2 1 item
  14. EZH2 1 item
  15. mTOR 1 item
  16. AP-1 2item
  17. MMP 1 item
  18. Myosin II ATPases 1 item
  19. FLT3 2item
  20. GSK-3 4item
  21. LPA Receptors 1 item
  22. P-glycoprotein (P-gp) 3item
  23. PLK 7item
  24. Chk 4item
  25. VEGFR 4item
  26. PDGFR 3item
  27. c-Kit 1 item
  28. Bromodomain-containing proteins(BRDs) 1 item
  29. Phosphodiesterases (PDEs) 2item
  30. Hydrolase 1 item
  31. p38 1 item
  32. MEK 1 item
  33. PORCN 1 item
  34. DOT1L 1 item
  35. FGFR 2item
  36. Glucagon-like peptide 1 (GLP-1) receptors 1 item
  37. Sir2-like Family Deacetylases (Sirtuins) 1 item
  38. Smoothened 2item
  39. Eukaryotic elongation factors 1 item
  40. Ras 1 item
  41. Trk Receptors 1 item
  42. STAT 4item
  43. Microtubules/Tubulins 4item
  44. Estrogen and Related Receptors 1 item
  45. EGFR 6item
  46. Hedgehog 1 item
  47. ROCK 8item
  48. JAK 5item
  49. p300 1 item
  50. Stearoyl-CoA 9-desaturase (SCD-1) 1 item
  51. Syk 1 item
  52. DNA-PK 1 item
  53. HSP90 1 item
  54. AMPK 2item
  55. CFTR 3item
  56. TNKS 1 item
  57. Cytochrome P450 (CYP450) 1 item
  58. ErbB 2item
  59. Toll-like receptors (TLRs) 2item
  60. DNA Methyltransferases 1 item
  61. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) 1 item
  62. ERK 1 item
  63. BMI-1 1 item
  64. PKC 6item
  65. Ca2 /calmodulin-dependent protein kinases (CaMKs) 1 item
  66. Lyn 1 item
  67. SGLT 1 item
  68. RAD51 1 item
  69. LRRK2 2item
  70. Voltage-gated Calcium Channels (CaV) 1 item
  71. ALK 1 item
  72. Sphingosine kinases (SphKs) 1 item
  73. PKG 1 item
  74. PKA 3item
  75. Myosin light chain kinases (MLCKs) 1 item
  76. Fatty-acid-binding proteins (FABPs) 1 item
  77. Tie-2 1 item
  78. RSK 1 item
  79. Free Fatty Acid Receptors 1 item
  80. phosphatases 1 item
  81. Autophagy 2item
  82. ATM/ATR 2item
  83. Farnesyl Diphosphate Synthases 1 item
  84. Melatonin Receptors 1 item
  85. Peroxynitrite 1 item
  86. MAGL 1 item
  87. NPY Receptors 1 item
  88. Histamine H1 Receptors 3item
  89. TRP Channel 1 item
  90. MNK 1 item
  91. NO Donors / Precursors 1 item
  92. Glucocorticoid Receptors 1 item
  93. IL Receptors 1 item
  94. 15-lipoxygenases 1 item
  95. Inward Rectifier Potassium (Kir) Channels 2item
  96. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  97. NMDA receptor 1 item
  98. Aldosterone receptor 1 item
  99. DPP-4 1 item
  100. DREADD Ligands 1 item
  101. p70 rsk 1 item
  102. Microtubule/Tubulin 1 item
  103. p53-MDM2 interaction 1 item
  104. KDR 1 item
  105. p53 3item
  106. c-Fms tyrosine kinase 1 item
  107. insulin 1 item
  108. Ub-conjugating enzyme (E2) complex 1 item
  109. Smoothened receptor 1 item
  110. PPAR 1 item
  111. HDM2 ubiquitin ligase 1 item
  112. MSK 1 item
  113. Glucosidases 1 item
  114. Vitamin D receptors (VDRs) 1 item
  115. Antibiotic 1 item
  116. DNA Alkylating 1 item
  117. GLI 1 item
  118. Stem Cell Differentiation 1 item
  119. PP2A/Nkd interaction 1 item
  120. adrenergic receptor 1 item
  121. Ribonucleotide Reductases 1 item
  122. Aryl hydrocarbon receptors (AHRs) 1 item
  123. DCLK2 1 item
  124. phosphatidylinositol kinase 1 item
  125. Adenosine Deaminases 1 item
  126. Histamine receptors 1 item
  127. GluR 1 item
  128. 5-HT receptor 1 item
  129. dopamine receptors 1 item
  130. AMPA receptor 1 item
  131. Flk1 1 item
  132. p21 1 item
  133. RHA 1 item
  134. TRPC channel 1 item
  135. FKBP 1 item
  136. Bcl-w 1 item
  137. PPK 1 item
  138. c-Syk 1 item
  139. CDK1/CyclinB 1 item
  140. FXR 1 item
  141. Vascular Disrupting Agents (VDA) 1 item
  142. Sirtuin 1 item
  143. PIKfyve 1 item
  144. Bax 1 item
  145. NS3/4a Proteases 1 item
  146. p90 S6K 1 item
Related Disease
  1. Acne 1 item
  2. Acute Myelogenous Leukemia 1 item
  3. Acute Myeloid Leukemia 7item
  4. Autoimmune Diseases 1 item
  5. Bladder Cancer 4item
  6. B-lymphoid Malignancies 1 item
  7. Breast Cancer 32item
  8. Cancer 126item
  9. Cholangiocarcinoma 1 item
  10. Chronic Lymphocytic Leukemia 2item
  11. Colon Cancer 11item
  12. Colon Carcinoma 1 item
  13. Colorectal Cancer 13item
  14. Diabetes 3item
  15. Fungal Infection 1 item
  16. Glioblastoma 7item
  17. Glioma 2item
  18. HCV 1 item
  19. Hepatocellular Carcinoma 3item
  20. Immunosuppressive Therapy 1 item
  21. Inflammatory Diseases 4item
  22. Leukemia 7item
  23. Liver Cancer 2item
  24. Lung Cancer 5item
  25. Lymphoma 4item
  26. Mantle Cell Lymphoma 2item
  27. Medulloblastoma 1 item
  28. Melanoma 11item
  29. Mixed Lineage Leukemia 1 item
  30. Multiple Myeloma 5item
  31. Neuroblastoma 2item
  32. Non-small Cell Lung Cancer 6item
  33. Non-small Cell Lung Carcinoma 1 item
  34. Ovarian Cancer 9item
  35. Pain Relief 1 item
  36. Pancreatic Cancer 11item
  37. Pancreatic Carcinoma 2item
  38. Prostate Cancer 12item
  39. Psoriasis 2item
  40. Pulmonary Fibrosis 1 item
  41. Renal Cell Carcinoma 2item
  42. Rheumatoid Arthritis 2item
  43. Sleep Disorders 1 item
  44. Type 2 Diabetes 3item